| Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. M Andersson, J Alvarez-Cermeno, G Bernardi, I Cogato, P Fredman, ... Journal of Neurology, Neurosurgery & Psychiatry 57 (8), 897-902, 1994 | 989 | 1994 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 645 | 2019 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 389 | 2015 |
| Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS LM Villar, MC Sádaba, E Roldán, J Masjuan, P González-Porqué, ... The Journal of clinical investigation 115 (1), 187-194, 2005 | 337 | 2005 |
| Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis M Comabella, M Fernández, R Martin, S Rivera-Vallve, E Borrás, C Chiva, ... Brain 133 (4), 1082-1093, 2010 | 323 | 2010 |
| Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis LM Villar, J Masjuan, P González‐Porqué, J Plaza, MC Sádaba, E Roldán, ... Annals of Neurology: Official Journal of the American Neurological …, 2003 | 224 | 2003 |
| Telemedicine as a tool for intensive management of diabetes: the DIABTel experience EJ Gómez, ME Hernando, A Garcıa, F Del Pozo, J Cermeno, R Corcoy, ... Computer methods and programs in biomedicine 69 (2), 163-177, 2002 | 212 | 2002 |
| Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes E Canto, M Tintore, LM Villar, C Costa, R Nurtdinov, JC Alvarez-Cermeno, ... Brain 138 (4), 918-931, 2015 | 205 | 2015 |
| A telemedicine support for diabetes management: the T-IDDM project R Bellazzi, C Larizza, S Montani, A Riva, M Stefanelli, G d'Annunzio, ... Computer methods and programs in biomedicine 69 (2), 147-161, 2002 | 188 | 2002 |
| Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS J Masjuan, JC Alvarez-Cermeno, N Garcia-Barragan, M Díaz-Sánchez, ... Neurology 66 (4), 576-578, 2006 | 170 | 2006 |
| Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS LM Villar, J Masjuan, P González-Porqué, J Plaza, MC Sádaba, E Roldán, ... Neurology 59 (4), 555-559, 2002 | 164 | 2002 |
| Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis C Teunissen, T Menge, A Altintas, JC Álvarez-Cermeño, A Bertolotto, ... Multiple Sclerosis Journal 19 (13), 1802-1809, 2013 | 161 | 2013 |
| Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome C Matute-Blanch, LM Villar, JC Álvarez-Cermeño, K Rejdak, ... Brain 141 (4), 1085-1093, 2018 | 155 | 2018 |
| Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus M Sepúlveda, T Armangué, N Sola-Valls, G Arrambide, JE Meca-Lallana, ... Neuroimmunology & Neuroinflammation 3 (3), e225, 2016 | 155 | 2016 |
| Neurofilament light chain level is a weak risk factor for the development of MS G Arrambide, C Espejo, H Eixarch, LM Villar, JC Alvarez-Cermeño, ... Neurology 87 (11), 1076-1084, 2016 | 124 | 2016 |
| Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS LM Villar, J Masjuan, P González–Porqué, J Plaza, MC Sádaba, E Roldán, ... Neurology 58 (5), 824-826, 2002 | 113 | 2002 |
| Influence of oligoclonal IgM specificity in multiple sclerosis disease course LM Villar, N García-Barragán, M Espiño, E Roldán, MC Sádaba, ... Multiple Sclerosis Journal 14 (2), 183-187, 2008 | 105 | 2008 |
| Comparative diagnostic accuracy of ganglion cell‐inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in … JJ González-López, G Rebolleda, M Leal, N Oblanca, FJ Muñoz-Negrete, ... BioMed Research International 2014 (1), 128517, 2014 | 101 | 2014 |
| Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis M Thangarajh, J Gomez-Rial, AK Hedström, J Hillert, ... Multiple Sclerosis Journal 14 (9), 1208-1213, 2008 | 96 | 2008 |
| Metabolomic signatures associated with disease severity in multiple sclerosis P Villoslada, C Alonso, I Agirrezabal, E Kotelnikova, I Zubizarreta, ... Neurology: Neuroimmunology & Neuroinflammation 4 (2), e321, 2017 | 95 | 2017 |
